Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multidrug Resistance–Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma

6 Apr 2012

Abstract excerpt

PURPOSE: This study assesses the ability of multidrug resistance (MDR)-associated gene expression patterns to predict survival in patients with newly diagnosed carcinoma of the ovary. The scope of this research differs substantially from that of previous reports, as a very large set of genes was evaluated whose expression has been shown to affect response to chemotherapy. EXPERIMENTAL DESIGN: We applied a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22492981
DOI: 10.1158/1078-0432.ccr-12-0056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multidrug Resistance–Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous CarcinomaPMID 22492981Read ↗

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.Semantic proximity Read ↗

Survival-Related Profile, Pathways, and Transcription Factors in Ovarian CancerSemantic proximity Read ↗

Prediction of chemo-response in serous ovarian cancerSemantic proximity Read ↗

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapySemantic proximity Read ↗

Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian CancerSemantic proximity Read ↗

Analysis of chromosomal changes in serous ovarian carcinoma using high‐resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant diseaseSemantic proximity Read ↗

Molecular profiling of platinum resistant ovarian cancerSemantic proximity Read ↗

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patientsSemantic proximity Read ↗

A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based ChemotherapySemantic proximity Read ↗

Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samplesSemantic proximity Read ↗

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer CellsSemantic proximity Read ↗

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.